more than 0.3% THC, it is considered cannabis and is illegal on a federal level. The Drug Enforcement Administration (DEA) considers these products with more than 0.3% THC to be Schedule 1 controlled substances, meaning they have no accepted medical use and a high potential for abuse. or hemp, plants that is not considered to have effects typically associated with the “high” of marijuana. THC is the active ingredient in marijuana that gives users the feeling of being “high.” Plants with less than 0.3% of THC are often just referred to as hemp.
Not enough is known about CBD to fully understand how it can interact with medications. Experts warn not to consume CBD products if you are on medications such as blood thinners.
The Department of Transportation’s Drug and Alcohol Testing Regulation, Part 40, does not authorize the use of Schedule I drugs, including marijuana, for any reason. Furthermore, CBD use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive result. Therefore, Medical Review Officers will verify a drug test confirmed CBD gummies at the appropriate cutoffs as positive, even if an employee claims they only used a CBD product. FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety.
You cannot 100% prove that you consumed CBD products rather than cannabis. However, if you keep the receipt, the box the CBD oil came in, and even keep your statement from the bank showing the purchase, you can prove that you are consuming CBD oil and not getting high while consuming cannabis.
The benefits of CBD are not proven, but the risks seem to be clear. Reported side effects of CBD products may include fatigue, drowsiness, reduced appetite, dry mouth, and diarrhea. Some research in animals has shown that CBD could also harm your liver and central nervous system.
This is based on studies of patients with Dravet syndrome and Lennox-Gastaut syndrome (LGS). These two childhood epilepsy syndromes typically do not respond to anti-seizure medications.